Società Italiana di Allergologia, Asma e Immunologia Clinica
To represent real-world mild moderate Italian asthmatics, all adults with diagnosed asthma by specialist, according GINA (Global Initiative for Asthma) document, attending respiratory or allergy clinic for a scheduled visit are eligible for study enrollment. If inclusion/exclusion criteria are satisfied, a written consent to participate in the study will be obtained and an informative leaflet for the patient and his/her general practitioners will be delivered.
Subjects follow up will be scheduled according with GINA document and center plan (6 or 12 months follow up visit).
Age
18–99
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Adult patients
Asthma diagnosis according GINA 2020 algorithm (Annex 1)
Patients enrolled in other previous or ongoing observational studies
You may not be if
Severe asthma patients according International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma. \[Chung KF et al. European Respiratory Journal Feb 2014, 43 (2) 343-373; DOI: 10.1183/09031936.00202013 (Annex 2)\]
Subjects are excluded from this cohort if they exhibit interstitial lung diseases, pulmonary neoplasms, current lung infections, immunological disorders leading to the use of immunosuppressants or continuous treatment with oral steroids.